ERNAW
Ernexa Therapeutics Inc. Warrants • NASDAQ
$0.03 ▼ -14.00% (-0.00)
ERNAW
Ernexa Therapeutics Inc. WarrantsNASDAQ • $0.03 ▼ -14.00% (-0.00)
Market Cap $236378
52w High $0.04
52w Low $0.03
P/E 0
Volume 66
Outstanding Shares 7.85M
Market Cap $236378
52w High $0.04
52w Low $0.03
P/E 0
Volume 66
Outstanding Shares 7.85M
About Ernexa Therapeutics Inc. Warrants
https://www.ernexatx.comErnexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease.
CEO
Sanjeev Luther
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Asset Management
Sector Financial Services
Went public July 12, 2024
Method of going public IPO
Full time employees 6
MAY
20 WED
Upcoming Earnings
Date May 20, 2026
Day Wednesday
Revenue Est. —
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0